Molecular imaging technology has permitted an increasing development of the overall diagnostic accuracy of cancer in the last years. Design of individually suited therapies, accurate tumor staging, response evaluation, early detection of recurrence and distant lesions have also evolved accompanied by the development of novel molecular imaging technologies. To assess immunotherapy response early in the treatment cycle, Creative Biolabs launches the VisiMonitor™ 18F-FAraG PET tracer to provide a clinic treatment with an imaging tool for immune-modulating therapy.
PET has three key advantages including quantitative capability, high sensitivity, and limitless depth of penetration. In the last years, few PET tracers have been employed for imaging the immune system, and even less for specific imaging of distinct immune cell types such as activated T cells.
18F-FaraG is an analog of arabinosyl guanine (AraG) and a compound that is identified to have specific cytotoxicity towards T-lymphocytes and T-lymphoblastoid cells.
18F-FAraG PET tracer is a novel imaging tool to visualize immune response. 18F-FAraG PET imaging of a murine aGVHD model enabled visualization of secondary lymphoid organs harboring activated donor T cells before clinical symptoms. In addition, tracer biodistribution in healthy humans has shown favorable kinetics (shown as Fig.1).
Fig.1 Whole body PET images of 18F-FAraG in a healthy human volunteer. (Ronald, 2017)
Molecular imaging using novel tracers for PET can achieve the in situ detection of T-cells in living organisms. After transporting inside the cell by nucleoside transporters, 18F-FAraG is phosphorylated by cytoplasmic deoxycytidine and mitochondrial deoxyguanosine kinases, trapping PET probe in the cell. 18F-FAraG has exhibited high specificity for activated T-cells in vitro and in models of graft-versus-host disease, inflammatory arthritis and cancer. Moreover, 18F-FAraG imaging may provide a novel method for imaging of activated T cell dynamics in living subjects without toxicity since the tracer is given in very low (ng-μg) mass levels.
For more details about our VisiMonitor™ 18F-FAraG PET tracer, please do not hesitate to contact us.
References
For Research Use Only | Not For Clinical Use